Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CONNORS TA")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

DRUGS USED IN THE TREATMENT OF CANCER.CONNORS TA.1975; F.E.B.S. LETTERS; NETHERL.; DA. 1975; VOL. 57; NO 3; PP. 223-233; BIBL. 29 REF.Article

ALKYLATING AGENTSCONNORS TA.1974; TOPICS CURR. CHEM.; GERM.; DA. 1974; VOL. 52; PP. 141-171; BIBL. 2 P. 1/2Article

ALKYLATING DRUGS, NITROSOUREAS AND ALKYLTRIAZENESCONNORS TA.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 29-50; BIBL. 159 REF.Article

IN VITRO STUDIES WITH HEXAMETHYLMELAMINE.RUTTY CJ; CONNORS TA.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 24; PP. 2385-2391; BIBL. 25 REF.Article

THE BINDING OF 14C LABELLED (1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (CCNU) TO MACROMOLECULES OF SENSITIVE AND RESISTANT TUMOURS = FIXATION DE LA (CHLORO-2 ETHYL)-1 CYCLOHEXYL-3 NITROSO-1 UREE (CCNU) AUX MACROMOLECULES DES TUMEURS SENSIBLES ET RESISTANTESCONNORS TA; HARE JR.1974; BRIT. J. CANCER; G.B.; DA. 1974; VOL. 30; NO 5; PP. 477-480; BIBL. 20REF.Article

STUDIES OF THE MECAHNISM OF ACTION OF THE TUMOUR-INHIBITORY NITROSOUREAS.CONNORS TA; HARE JR.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 23; PP. 2133-2140; BIBL. 28 REF.Article

PHARMACOLOGICALLY ACTIVE POLYMERS, 13. ELUCIDATION OF THE TUMOUR AFFINITY OF POLY (SULFADIAZINEARCRYLAMIDE).ABEL G; CONNORS TA; HOFMANN V et al.1976; MAKROMOLEK. CHEM.; SCHWEIZ; DA. 1976; VOL. 177; NO 9; PP. 2669-2674; ABS. ALLEM.; BIBL. 6 REF.Article

METHYLATION OF CYSTEINE IN HEMOGLOBIN FOLLOWING EXPOSURE TO METHYLATING AGENTSBAILEY E; CONNORS TA; FARMER PB et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 6; PP. 2514-2517; BIBL. 16 REF.Article

APPROACH TO THE QUANTITATION OF ALKYLATED AMINO ACIDS IN HAEMOGLOBIN BY GAS CHROMATOGRAPHY MASS SPECTROMETRYFARMER PB; BAILEY E; LAMB JH et al.1980; BIOMED. MASS SPECTROM.; GBR; DA. 1980; VOL. 7; NO 1; PP. 41-46; BIBL. 19 REF.Article

AN ATHYMIC NUDE MUTATION IN THE RAT.FESTING MFW; MAY D; CONNORS TA et al.1978; NATURE; GBR; DA. 1978; VOL. 274; NO 5669; PP. 365-366; BIBL. 5 REF.Article

PREPARATION AND ANTITUMOR ACTIVITY OF 1-ARYL-3,3-DIMETHYLTRIAZENE DERIVATIVES.GIRALDI T; NISI C; CONNORS TA et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 6; PP. 850-853; BIBL. 12 REF.Article

THE RELATIONSHIP BETWEEN THE PHARMACOKINETICS OF INTRAVENOUS CISMETHRIN AND BIORESMETHRIN AND THEIR MAMMALIAN TOXICITYGRAY AJ; CONNORS TA; HOELLINGER H et al.1980; PESTIC. BIOCHEM. PHYSIOL.; ISSN 0048-3575; USA; DA. 1980; VOL. 13; NO 3; PP. 281-293; BIBL. 14 REF.Article

THE CLINICAL PHARMACOLOGY OF A HEPATOMA-SPECIFIC ALKYLATING AGENT.CURT GA; CONNORS TA; MURRAY LYON IM et al.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 18; PP. 1715-1718; BIBL. 5 REF.Article

THE METABOLISM OF THE ANTI-TUMOUR AGENT 1(1-AZIRIDINYL)-2,4-DINITROBENZENE (CB 1837). = LE METABOLISME DE L'AGENT ANTITUMORAL (AZIRIDINYL-1)-1 DINITRO-2,4 BENZENE (CB 1837)CONNORS TA; HICKMAN JA; JARMAN M et al.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 18; PP. 1665-1670; BIBL. 13 REF.Article

TREATMENT OF A MOUSE LYMPHOMA BY L-ASPARAGINASE: SUCCESS DEPENDS ON THE HOST'S IMMUNE RESPONSECARTER RL; CONNORS TA; WESTON BJ et al.1973; INTERNATION. J. CANCER; SWITZ.; DA. 1973; VOL. 11; NO 2; PP. 345-357; ABS. FR.; BIBL. 18REF.Serial Issue

THE SELECTIVE CONCENTRATION OF SULPHADIAZINE AND RELATED COMPOUNDS IN MALIGNANT TISSUEABEL G; CONNORS TA; ROSS WCJ et al.1973; EUROP. J. CANCER; G.B.; DA. 1973; VOL. 9; NO 1; PP. 49-54; BIBL. 7REF.Serial Issue

NEW PLATINUM COMPLEXES WITH ANTI-TUMOUR ACTIVITYCONNORS TA; JONES M; ROSS WCJ et al.1972; CHEMICO-BIOL. INTERACTIONS; NETHERL.; DA. 1972; VOL. 5; NO 6; PP. 415-424; BIBL. 1 P.Serial Issue

STRUCTURE AND ACTIVITY RELATIONSHIPS OF PLATINUM COMPLEXES WITH ANTI-TUMOUR ACTIVITY.BRADDOCK PD; CONNORS TA; JONES M et al.1975; CHIMICO-BIOL. INTERACTIONS; NETHERL.; DA. 1975; VOL. 11; NO 3; PP. 145-161; BIBL. 10 REF.Article

CYTOTOXIC SULPHONAMIDES DESIGNED FOR SELECTIVE DEPOSITION IN MALIGNANT TISSUE.ABEL G; CONNORS TA; GODDARD P et al.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 11; PP. 787-793; BIBL. 5 REF.Article

EXPERIMENTAL SCREENING OF 3FORMS AND 19DERIVATIVES OR ANALOGIS OF ELLIPTICINE. ONCOSTATIC EFFECT ON L 1210 LEUKAEMIA AND IMMUNOSUPPRESSIVE EFFECT OF 4 OF THEMHAYAT M; MATHE G; JANOT MM et al.1974; BIOMEDICINE; FR.; DA. 1974; VOL. 21; NO 3; PP. 101-106; ABS. FR.; BIBL. 14REF.Article

  • Page / 1